Botulinum Toxin Injections for Oral Neuropathic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

July 19, 2022

Study Completion Date

November 8, 2022

Conditions
Trigeminal Neuropathy, Traumatic
Interventions
DRUG

BOTOX®, Allergan

50 U BTX-A (BOTOX®, Allergan) powder diluted in 2 mL saline solution (0.9% NaCl) administrated at visit 2 by intra oral injection

DRUG

Placebo

2 mL saline solution (0.9% NaCl) administrated at visit 2 by intra oral injection

Trial Locations (1)

Unknown

Groupe Hospitalier Pitié-Salpêtrière, Paris

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

University of Aarhus

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03555916 - Botulinum Toxin Injections for Oral Neuropathic Pain | Biotech Hunter | Biotech Hunter